Get the Stockscreener App
219.31
1.23%
-2.74
After Hours:
219.31
Bio Rad Laboratories Inc stock is traded at $219.31, with a volume of 263.16K.
It is down -1.23% in the last 24 hours and down -8.69% over the past month.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
See More
Previous Close:
$222.05
Open:
$222.1
24h Volume:
263.16K
Relative Volume:
0.71
Market Cap:
$4.86B
Revenue:
$2.58B
Net Income/Loss:
$-778.69M
P/E Ratio:
-8.0245
EPS:
-27.33
Net Cash Flow:
$223.75M
1W Performance:
-3.65%
1M Performance:
-8.69%
6M Performance:
-31.97%
1Y Performance:
-24.14%
1-Day Range:
$218.14
$223.57
1-Week Range:
$211.43
$228.33
52-Week Range:
$211.43
$387.99
Bio Rad Laboratories Inc Stock (BIO) Company Profile
Name
Bio Rad Laboratories Inc
Sector
Industry
Phone
(510) 724-7000
Address
1000 ALFRED NOBEL DRIVE, HERCULES
Compare BIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
219.31 | 6.19B | 2.58B | -778.69M | 223.75M | -27.33 |
|
ABT
Abbott Laboratories
|
133.94 | 231.14B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.83 | 154.60B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
383.10 | 146.12B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
87.00 | 105.64B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.77 | 45.60B | 5.54B | 4.18B | 623.10M | 7.00 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-01-24 | Upgrade | Citigroup | Neutral → Buy |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Apr-03-24 | Downgrade | Citigroup | Buy → Neutral |
| Dec-07-23 | Initiated | UBS | Buy |
| Jun-16-23 | Initiated | Wells Fargo | Overweight |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jan-28-22 | Reiterated | Citigroup | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Oct-17-18 | Initiated | Goldman | Buy |
| Sep-20-18 | Initiated | Morgan Stanley | Equal-Weight |
| Feb-16-18 | Downgrade | CL King | Buy → Neutral |
| Jul-13-17 | Initiated | Wells Fargo | Outperform |
| Jun-28-17 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-18-17 | Initiated | Deutsche Bank | Hold |
| Oct-13-16 | Initiated | CL King | Buy |
| May-06-15 | Reiterated | Jefferies | Buy |
| Dec-18-09 | Initiated | Maxim Group | Buy |
| Nov-06-09 | Initiated | Jefferies & Co | Buy |
| Jul-17-09 | Initiated | Soleil | Buy |
| Sep-26-07 | Initiated | Banc of America Sec | Buy |
| Feb-23-07 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Bio Rad Laboratories Inc Stock (BIO) Latest News
Laboratory Proficiency Testing Market Set to Witness - openPR.com
Minimal Residual Disease Testing Market Set to Witness - openPR.com
bio-rad laboratories stock highlighted in cantor fitzgerald report By Investing.com - Investing.com UK
Enzyme Linked Immunosorbent Assay Market reached US$ 2.14 - openPR.com
Flow Cytometry Market Growth, Trends & Forecast 2025 | Global - openPR.com
Immunohistochemistry Market Detailed in New Research Report - openPR.com
Here’s Why Bio-Rad Laboratories (BIO) Traded Lower in Q1 - Insider Monkey
Global Microarray Market Size, Share & Growth Forecast - openPR.com
How DNA Sequencing Is Revolutionizing Cancer Genomics and Rare - openPR.com
Epigenetics Market Anticipated to Achieve 11.8% CAGR - GlobeNewswire Inc.
Cell Viability Assays Market 2025 | Techniques, Applications & - openPR.com
High Resolution Melting Analysis Market Detailed in New - openPR.com
Gel Documentation Systems Market Projected to Witness Massive - openPR.com
Cell Signaling Market in 2025-2032 Detailed Study Analysis with - openPR.com
Neuroscience Antibodies and Assays Market Trends, Growth & - openPR.com
Bio-Rad Laboratories, Inc. (NYSE:BIO) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
Learn to Evaluate (BIO) using the Charts - news.stocktradersdaily.com
Bio-Rad Laboratories (NYSE:BIO) Stock Rating Upgraded by Wall Street Zen - Defense World
Protein Characterization and Identification Market Is Booming WorldwideBio-Rad Laboratories, Agilent Technologies - openPR.com
Electrophoresis Reagents Market Detailed in New Research ReportBio-Rad Laboratories, Thermo Fisher Scientific - openPR.com
Bio-Rad's Management to Host Investor Meetings During Jefferies Global Healthcare Conference | BIO Stock News - GuruFocus
Bio-Rad’s Management to Host Investor Meetings During Jefferies Global Healthcare Conference - Business Wire
Syphilis Market Growth Projections 2023-2032: DelveInsight - openPR.com
Cell Analysis Market Deep Research Report Highlights New DevelopmentsBD Biosciences, Bio-Rad - openPR.com
Hemoglobin A1c Testing Devices Market To Witness Substantial - openPR.com
Difficult-to-Express Proteins Market Expansion Driven - openPR.com
Salmonella Testings Market to Witness Stunning Growth with Thermo Fisher, Bio-Rad, Merck - openPR.com
Flow Cytometry Market Deep Research with Forecast By 2025-2032 | - openPR.com
Protein Assays Market Set to Witness Significant Growth - openPR.com
Nuveen Asset Management LLC Increases Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - Defense World
Enzyme Linked Immunosorbent Assay Market Survey Detailed - openPR.com
Global Clinical Microbiology Market Trends, Growth & Analysis - openPR.com
Zacks Research Issues Negative Forecast for BIO Earnings - Defense World
Zacks Research Has Positive Outlook of BIO FY2027 Earnings - Defense World
Medical Biosensors Market 2025 | Latest Trends, Growth Forecast - openPR.com
Bio-Rad’s SWOT analysis: life science firm navigates tariffs, eyes growth - Investing.com Canada
Bio-Rad at RBC Healthcare Conference: Strategic Focus Amid Challenges - Investing.com Australia
Bio-Rad at RBC Healthcare Conference: Strategic Focus Amid Challenges By Investing.com - Investing.com Nigeria
Transcript : Bio-Rad Laboratories, Inc. Presents at RBC Capital Markets Global Healthcare Conference 2025, May-21-2025 01 - marketscreener.com
Bio-Rad Laboratories Inc (BIO) Stock Price Down 4.42% on May 21 - GuruFocus
Polymerase Chain Reaction Market Deep Research Report with - openPR.com
Multiplex assays Market Set to Witness Significant Growth - openPR.com
Bio-Rad Laboratories, Inc. (NYSE:BIO) Stock Position Increased by Ameriprise Financial Inc. - Defense World
Protein Chip Industry Forecast: Clean Ingredients, - openPR.com
Bio Rad Laboratories Inc Stock (BIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.61%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):